首页 | 本学科首页   官方微博 | 高级检索  
检索        


The neuropsychological outcome of pediatric patients with refractory epilepsy treated with VNS — A 24-month follow-up in Taiwan
Institution:1. School of Medicine, Chung Shan Medical University, Taichung, Taiwan;2. Department of Pediatrics, Chung Shan Medical University Hospital, Taichung, Taiwan;3. Department of Pediatrics, Chang Gung Memorial Hospital, Kaohsiung, Taiwan;4. Department of Pediatrics, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan;5. Department of Pediatrics, Cathay General Hospital, Taipei, Taiwan;6. School of Medicine, Fu-Jen Catholic University, New Taipei, Taiwan;7. Vagus Nerve Stimulation Study Group of Taiwan Child Neurology Society, Taiwan;1. Department of Neurosurgery, Fuzhou General Hospital of Nanjing Command, PLA, Fuzhou 350025, China;2. Department of Epileptology, Fuzhou General Hospital of Nanjing Command, PLA, Fuzhou 350025, China;3. Department of Medical Imaging, Fuzhou General Hospital of Nanjing Command, PLA, Fuzhou 350025, China
Abstract:ObjectivesMultiple studies have reported the benefits of vagus nerve stimulation (VNS) on neuropsychological outcomes. The aim of this study was to investigate how VNS affects cognition and psychosocial adjustment in children with refractory epilepsy (RE), and to determine the efficacy of VNS in a Taiwanese population.MethodsWe conducted a one-group pretest–posttest study on pediatric patients with RE. The study comprised 19 males and 18 females, all aged < 18 years. We recorded seizure frequency at 3, 12, and 24 months after VNS device implantation. Intelligence quotients (IQ) were assessed using the Wechsler Intelligence Scale for Children — IV. The Parental Stress Index (PSI) scores were evaluated by a pediatric psychologist.ResultsVagus nerve stimulation device implantation significantly reduced seizure frequency at 3, 12 and 24 months, especially in young children (< 12 years). No significant improvement in IQ test performance was observed, though there were significant improvements in the PSI, especially in young children.ConclusionsVagus nerve stimulation device implantation does not significantly improve cognition function, but it does significantly reduce seizure frequency and stress in parent–child relationships, especially in young children (< 12 years). These findings suggest that VNS should be considered as an alternative therapy for patients proven to have seizures that are medically refractory, especially those younger than 12 years of age.
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号